Literature DB >> 22561546

Pax6: a multi-level regulator of ocular development.

Ohad Shaham1, Yotam Menuchin, Chen Farhy, Ruth Ashery-Padan.   

Abstract

Eye development has been a paradigm for the study of organogenesis, from the demonstration of lens induction through epithelial tissue morphogenesis, to neuronal specification and differentiation. The transcription factor Pax6 has been shown to play a key role in each of these processes. Pax6 is required for initiation of developmental pathways, patterning of epithelial tissues, activation of tissue-specific genes and interaction with other regulatory pathways. Herein we examine the data accumulated over the last few decades from extensive analyses of biochemical modules and genetic manipulation of the Pax6 gene. Specifically, we describe the regulation of Pax6's expression pattern, the protein's DNA-binding properties, and its specific roles and mechanisms of action at all stages of lens and retinal development. Pax6 functions at multiple levels to integrate extracellular information and execute cell-intrinsic differentiation programs that culminate in the specification and differentiation of a distinct ocular lineage.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561546     DOI: 10.1016/j.preteyeres.2012.04.002

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  94 in total

1.  Xenopus pax6 mutants affect eye development and other organ systems, and have phenotypic similarities to human aniridia patients.

Authors:  Takuya Nakayama; Marilyn Fisher; Keisuke Nakajima; Akinleye O Odeleye; Keith B Zimmerman; Margaret B Fish; Yoshio Yaoita; Jena L Chojnowski; James D Lauderdale; Peter A Netland; Robert M Grainger
Journal:  Dev Biol       Date:  2015-02-25       Impact factor: 3.582

Review 2.  Epithelial morphogenesis: the mouse eye as a model system.

Authors:  Bharesh Chauhan; Timothy Plageman; Ming Lou; Richard Lang
Journal:  Curr Top Dev Biol       Date:  2015-01-22       Impact factor: 4.897

Review 3.  Transcriptional regulation of cranial sensory placode development.

Authors:  Sally A Moody; Anthony-Samuel LaMantia
Journal:  Curr Top Dev Biol       Date:  2015-01-22       Impact factor: 4.897

Review 4.  Applying evolutionary genetics to developmental toxicology and risk assessment.

Authors:  Maxwell C K Leung; Andrew C Procter; Jared V Goldstone; Jonathan Foox; Robert DeSalle; Carolyn J Mattingly; Mark E Siddall; Alicia R Timme-Laragy
Journal:  Reprod Toxicol       Date:  2017-03-04       Impact factor: 3.143

5.  Aberrant activation of p53 due to loss of MDM2 or MDMX causes early lens dysmorphogenesis.

Authors:  Yiwei Zhang; Xin Zhang; Hua Lu
Journal:  Dev Biol       Date:  2014-09-28       Impact factor: 3.582

Review 6.  Signaling and Gene Regulatory Networks in Mammalian Lens Development.

Authors:  Ales Cvekl; Xin Zhang
Journal:  Trends Genet       Date:  2017-08-31       Impact factor: 11.639

Review 7.  The MID1 gene product in physiology and disease.

Authors:  Rossella Baldini; Martina Mascaro; Germana Meroni
Journal:  Gene       Date:  2020-04-10       Impact factor: 3.688

8.  The ETS transcription factor Etv1 mediates FGF signaling to initiate proneural gene expression during Xenopus laevis retinal development.

Authors:  Minde Willardsen; David A Hutcheson; Kathryn B Moore; Monica L Vetter
Journal:  Mech Dev       Date:  2013-11-09       Impact factor: 1.882

9.  The stage-dependent roles of Ldb1 and functional redundancy with Ldb2 in mammalian retinogenesis.

Authors:  Keren Gueta; Ahuvit David; Tsadok Cohen; Yotam Menuchin-Lasowski; Hila Nobel; Ginat Narkis; LiQi Li; Paul Love; Jimmy de Melo; Seth Blackshaw; Heiner Westphal; Ruth Ashery-Padan
Journal:  Development       Date:  2016-10-03       Impact factor: 6.868

10.  PAX6 maintains β cell identity by repressing genes of alternative islet cell types.

Authors:  Avital Swisa; Dana Avrahami; Noa Eden; Jia Zhang; Eseye Feleke; Tehila Dahan; Yamit Cohen-Tayar; Miri Stolovich-Rain; Klaus H Kaestner; Benjamin Glaser; Ruth Ashery-Padan; Yuval Dor
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.